APA (7th ed.) Citation

Hajaj, E., Eisenberg, G., Klein, S., Frankenburg, S., Merims, S., David, I. B., . . . Lotem, M. (2020, March). SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. eLife.

Chicago Style (17th ed.) Citation

Hajaj, Emma, et al. "SLAMF6​ Deficiency Augments Tumor Killing and Skews Toward an Effector Phenotype Revealing It as a Novel T Cell Checkpoint." ELife Mar. 2020.

MLA (9th ed.) Citation

Hajaj, Emma, et al. "SLAMF6​ Deficiency Augments Tumor Killing and Skews Toward an Effector Phenotype Revealing It as a Novel T Cell Checkpoint." ELife, Mar. 2020.